SM-Youtube

1

An Update on the Multifaceted Roles of STAT3 in the Heart.

Harhous Z, Booz GW, Ovize M, Bidaux G, Kurdi M. Harhous Z, et al. Among authors: booz gw. Front Cardiovasc Med. 2019 Oct 25;6:150. doi: 10.3389/fcvm.2019.00150. eCollection 2019. Front Cardiovasc Med. 2019. PMID: 31709266 Free PMC article. Review.

2

Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components.

Kurdi M, De Mello WC, Booz GW. Kurdi M, et al. Among authors: booz gw. Int J Biochem Cell Biol. 2005 Jul;37(7):1357-67. doi: 10.1016/j.biocel.2005.01.012. Int J Biochem Cell Biol. 2005. PMID: 15833268 Review.

3

Jak inhibition, but not Stat1 knockdown, blocks the synergistic effect of IFN-gamma on Fas-induced apoptosis of A549 human non-small cell lung cancer cells.

Kurdi M, Booz GW. Kurdi M, et al. Among authors: booz gw. J Interferon Cytokine Res. 2007 Jan;27(1):23-31. doi: 10.1089/jir.2007.0074. J Interferon Cytokine Res. 2007. PMID: 17266440

4

Parthenolide induces a distinct pattern of oxidative stress in cardiac myocytes.

Kurdi M, Bowers MC, Dado J, Booz GW. Kurdi M, et al. Among authors: booz gw. Free Radic Biol Med. 2007 Feb 15;42(4):474-81. doi: 10.1016/j.freeradbiomed.2006.11.012. Epub 2006 Nov 15. Free Radic Biol Med. 2007. PMID: 17275679

5

Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: parthenolide targets JAK1 activation by generating ROS.

Kurdi M, Booz GW. Kurdi M, et al. Among authors: booz gw. J Cell Physiol. 2007 Aug;212(2):424-31. doi: 10.1002/jcp.21033. J Cell Physiol. 2007. PMID: 17385713

6

G-CSF-based stem cell therapy for the heart-unresolved issues part A: paracrine actions, mobilization, and delivery.

Kurdi M, Booz GW. Kurdi M, et al. Among authors: booz gw. Congest Heart Fail. 2007 Jul-Aug;13(4):221-7. doi: 10.1111/j.1527-5299.2007.07111.x. Congest Heart Fail. 2007. PMID: 17673875 Free article. Review.

7

Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signaling.

Kurdi M, Booz GW. Kurdi M, et al. Among authors: booz gw. J Cardiovasc Pharmacol. 2007 Aug;50(2):126-41. doi: 10.1097/FJC.0b013e318068dd49. J Cardiovasc Pharmacol. 2007. PMID: 17703129 Review.

8

G-CSF-based stem cell therapy for the heart--unresolved issues part B: Stem cells, engraftment, transdifferentiation, and bioengineering.

Kurdi M, Booz GW. Kurdi M, et al. Among authors: booz gw. Congest Heart Fail. 2007 Nov-Dec;13(6):347-51. doi: 10.1111/j.1527-5299.2007.07112.x. Congest Heart Fail. 2007. PMID: 18046094 Free article. Review.

9

Growing hearts by the bushel.

Kurdi M, Booz GW. Kurdi M, et al. Among authors: booz gw. Congest Heart Fail. 2008 Mar-Apr;14(2):95-6. doi: 10.1111/j.1751-7133.2008.08332.x. Congest Heart Fail. 2008. PMID: 18401219 Free article. No abstract available.

10

JAK redux: a second look at the regulation and role of JAKs in the heart.

Kurdi M, Booz GW. Kurdi M, et al. Among authors: booz gw. Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1545-56. doi: 10.1152/ajpheart.00032.2009. Epub 2009 Aug 28. Am J Physiol Heart Circ Physiol. 2009. PMID: 19717737 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

171 results

Search Page

Filters

My NCBI Filters

Search Results

171 results